Neoflow Technologies
NT
About
Neoflow Technologies Ltd. is a medical device startup focused on developing a novel endovascular solution for the treatment of vasospasm, a critical complication of aneurysmal subarachnoid hemorrhage (aSAH). Vasospasm can lead to delayed ischemic neurological deficit (DIND), a major cause of morbidity and mortality in aSAH patients.
Key facts
At-a-glance profile data
- Website
- neoflowtech.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2022
- Total funding
- $10M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2023 | Seed | $10M | Triventures |
Tech stack
Detected on neoflowtech.com, last scanned 8 Jun 2026. Run your own scan
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Neoflow Technologies raised?
Neoflow Technologies has raised a total of $10M in funding. The most recent round on record is Seed.
What is Neoflow Technologies's current status?
Neoflow Technologies's current operating status is: Inactive.